Amgen to buy KAI for $315M
Amgen said April 10 that it plans to buy San Francisco-based KAI Pharmaceuticals for $315 million in cash in a deal that would give it worldwide rights to an experimental treatment for patients with chronic kidney disease. Thousand Oaks-based Amgen said the deal would give it worldwide rights, excluding in Japan, to KAI’s lead product, Read More →
$350M CMH project will meet deadline
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Strawberries in a jam: Santa Maria grower tests mulch method
A Santa Maria farmer is leading the charge on growing strawberries in substances other than soil.
Op/ed: Nine tax-season conversation starters to ask your CPA
Posing a few more questions to your CPA during tax season could empower you to find and seize valuable benefits.
Firestone Walker puts food on tap at its Paso Robles brewery
Firestone Walker Brewing Co. has opened a dinner restaurant and bar.
Pawing at new ideas: Online advertising veterans want to move beyond the click
A group of online advertising veterans in Santa Barbara are working to move the industry beyond the click.
